Recalls / Active ingredient / Rizatriptan Benzoate

Rizatriptan Benzoate

9 FDA drug recalls involving the active ingredient “Rizatriptan Benzoate”.

Date	Class	Product	Firm
2025-07-09	Class II	Rizatriptan Benzoate Tablets, USP, 5 mg, 18 (3x6) Unit Dose Tablets, Rx Only, Manufactured by: Alkem Laborator	Ascend Laboratories, LLC
2025-07-09	Class II	Rizatriptan Benzoate Tablets, USP, 10 mg, 18 (3x6) Unit Dose Tablets, Rx Only, Manufactured by: Alkem Laborato	Ascend Laboratories, LLC
2024-05-13	Class II	Rizatriptan Benzoate Orally Disintegrating Tablets, USP 10mg, 18 (3 x 6) Unit-Dose Tablets, Manufactured for:	Glenmark Pharmaceuticals Inc., USA
2024-05-13	Class II	Rizatriptan Benzoate Orally Disintegrating Tablets, USP 5mg, 18 (3 x 6) Unit-Dose Tablets, Manufactured for: G	Glenmark Pharmaceuticals Inc., USA
2024-05-10	Class II	Rizatriptan Benzoate Tablets USP, 10 mg, 18 (3 X 6) Unit-Dose Tablets, Manufactured for: Glenmark Pharmaceutic	Glenmark Pharmaceuticals Inc., USA
2024-05-10	Class II	Rizatriptan Benzoate Tablets USP, 5mg, 18 (3 X 6) Unit-Dose Tablets, Manufactured for: Glenmark Pharmaceutical	Glenmark Pharmaceuticals Inc., USA
2021-10-18	Class III	Rizatriptan Benzoate Film Coated Tablets, 10 mg, packaged in a) 12 Tablets (2X6 Unit-Dose Tablets) Blister Pac	MACLEODS PHARMA USA, INC
2021-10-18	Class III	Rizatriptan Benzoate Orally Disintegrating Tablets 5mg, 12 Tablets (2 x 6 Unit-Dose Tablets) Blister Packs, Rx	MACLEODS PHARMA USA, INC
2021-10-18	Class III	Rizatriptan Benzoate Orally Disintegrating Tablets 10mg, 18 Tablets (3 x 6 Unit-Dose Tablets) Blister Packs, R	MACLEODS PHARMA USA, INC